Please Wait
Applying Filters...
menu
    • menu
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Mylinax

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 41,266Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    BioNxt Advances MS ODF Program Toward Human Trials
    BioNxt Advances MS ODF Program Toward Human Trials

    26 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-26/bionxt-accelerates-odf-for-multiple-sclerosis-toward-human-clinical-study-with-40-bioavailability

    PHARMIWEB
    26 Jan 2026
    Share Share
    BioNxt Announces Success in Final Cladribine ODF In Vivo Study
    BioNxt Announces Success in Final Cladribine ODF In Vivo Study

    19 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-19/bionxt-reports-successful-final-in-vivo-dosing-study-results-supporting-superior-bioavailability-of

    PHARMIWEB
    19 Jan 2026
    Share Share
    BioNxt Enhances Cladribine Formulation For MS Patients
    BioNxt Enhances Cladribine Formulation For MS Patients

    09 Dec 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/bionxt-advances-%22melt-in-your-mouth%22-cladribine-formulation-to-improv-1115793

    ACCESSWIRE
    09 Dec 2025
    Share Share
    Hopewell’s Generics Cladribine Receives Tentative Approval in US
    Hopewell’s Generics Cladribine Receives Tentative Approval in US

    04 Dec 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215547

    FDA
    04 Dec 2025
    Share Share
    Apotex’s Receives First Generic Approval for Cladribine in US
    Apotex’s Receives First Generic Approval for Cladribine in US

    24 Nov 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=218425

    FDA
    24 Nov 2025
    Share Share
    Bionxt Secures Eurasian Patent For Sublingual MS Therapy
    Bionxt Secures Eurasian Patent For Sublingual MS Therapy

    24 Nov 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/bionxt-secures-eurasian-patent-for-breakthrough-sublingual-ms-therapy-18336

    INDPHARMAPOST
    24 Nov 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.